A Potential High-Risk Clone of Pseudomonas aeruginosa ST463

Yanyan Hu1, Wenjing Peng2, Yifan Wu2

  • 1Clinical Microbiology Laboratory, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Zhejiang University, Hangzhou, China.

Insights

Multidrug-resistant Pseudomonas aeruginosa clones ST463, ST1212, and ST244 were identified in non-cystic fibrosis patients. ST463 isolates showed higher virulence due to pyocyanin production and diverse virulence genes, posing a significant clinical risk.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Genomics and Molecular Epidemiology

Background:

  • Pseudomonas aeruginosa is a frequent cause of nosocomial infections, characterized by multidrug resistance and hypervirulence.
  • Routine surveillance of epidemic P. aeruginosa clones is crucial for effective clinical management.
  • Understanding the interplay between antimicrobial resistance and virulence factors in prevalent clones is essential.

Purpose of the Study:

  • To investigate the relationship between virulence factors and antimicrobial resistance profiles in epidemic P. aeruginosa clones.
  • To identify prevalent sequence types (STs) and serotypes in P. aeruginosa isolates from non-cystic fibrosis patients.
  • To assess the virulence potential of identified clones using in vitro and in vivo models.

Main Methods:

  • Multilocus sequence typing (MLST) and serotyping were performed on 30 P. aeruginosa isolates.
  • Antimicrobial susceptibility testing and detection of resistance genes (e.g., blaKPC-2) were conducted.
  • Virulence gene profiling (exoU, exoS, pldA), pyocyanin quantification (LC/MS), hemolysis assays, and Galleria mellonella infection models were employed.

Main Results:

  • ST463 (O4), ST1212 (O11), and ST244 (O5) were identified as prevalent clones, all exhibiting multidrug resistance (MDR).
  • Resistance genes, including blaKPC-2 located within mobile genetic elements, were abundant.
  • ST463 isolates uniquely harbored exoU, exoS, and pldA, produced significant pyocyanin (0.2–3.2 μg/mL), and demonstrated higher virulence in hemolysis and G. mellonella models compared to other STs.

Conclusions:

  • Pyocyanin-producing ST463 P. aeruginosa, possessing a combination of virulence genes and MDR, represents a high-risk clone.
  • The study highlights the importance of molecular surveillance for identifying and characterizing virulent, drug-resistant clones in clinical settings.
  • Targeting specific virulence factors and resistance mechanisms in ST463 may offer novel therapeutic strategies.

Related Concept Videos